Abstract:Objectives Systemic lupus erythematosus (SLE), an autoimmune disease with incompletely understood etiology, has a strong genetic component. Although genome‐wide association studies (GWAS) have revealed multiple SLE susceptibility loci and associated single nucleotide polymorphisms (SNPs), the precise causal variants, target genes, cell types, tissues, and mechanisms of action remain largely unknown. Methods Here, we report a comprehensive post‐GWAS analysis using extensive bioinformatics, molecular modeling, and integrative functional genomic and epigenomic analyses to optimize fine‐mapping. We compile and cross‐reference immune cell‐specific expression quantitative trait loci (cis‐ and trans‐eQTLs) with promoter‐capture Hi‐C, allele‐specific chromatin accessibility, and massively parallel reporter assay data to define predisposing variants and target genes. We experimentally validate a predicted locus using CRISPR/Cas9 genome editing, qPCR, and Western blot. Results Anchoring on 452 index SNPs, we selected 9,931 high‐linkage disequilibrium (r2>0.8) SNPs and defined 182 independent non‐HLA SLE loci. The 3,746 SNPs from 143 loci were identified as regulating 564 unique genes. Target genes are enriched in lupus‐related tissues and associated with other autoimmune diseases. Of these, 329 SNPs (106 loci) showed significant allele‐specific chromatin accessibility and/or enhancer activity, indicating regulatory potential. Using CRISPR/Cas9, we validated rs57668933 as a functional variant regulating multiple targets, including SLE risk gene ELF1, in B‐cells. Conclusion We demonstrate and validate post‐GWAS strategies for utilizing multi‐dimensional data to prioritize likely causal variants with cognate gene targets underlying SLE pathogenesis. Our results provide a catalog of significantly SLE‐associated SNPs and loci, target genes, and likely biochemical mechanisms, to guide experimental characterization.

Genetics of SLE: evidence from mouse models

Atherosclerotic plaque vulnerability is increased in mouse model of lupus

Advances in Mouse Models of Lupus

Recent insights into the genetic basis of systemic lupus erythematosus

Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants

[Recent Advance in Genetics of Systemic Lupus Erythematosus].

Multiplex inheritance of component phenotypes in a murine model of lupus

Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy

Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus

Translating Lupus: Comparative Transcriptional Profiles of Preclinical Lupus Models and Their Relevance to Human Disease

The genetics of systemic lupus erythematosus and implications for targeted therapy

Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives

Recent research on mouse models of spontaneous lupus

[Rare Autoimmune Diseases Role of Genetics - Example of Systemic Lupus Erythematosus]

Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus

Production of Congenic Mouse Strains Carrying Genomic Intervals Containing SLE-susceptibility Genes Derived from the SLE-prone NZM2410 Strain.

Functional dissection of systemic lupus erythematosus using congenic mouse strains.

New Horizons In The Genetic Etiology Of Systemic Lupus Erythematosus And Lupus-Like Disease: Monogenic Lupus And Beyond

Sle3 and Sle5 Can Independently Couple with Sle1 to Mediate Severe Lupus Nephritis

Genetic Dissection Of Sle Pathogenesis: Sle3 On Murine Chromosome 7 Impacts T Cell Activation, Differentiation, And Cell Death

A multilayered post‐GWAS analysis pipeline defines functional variants and target genes for systemic lupus erythematosus (SLE)